Abstract
API Oration, Varanasi, January 2003 Improved glycemic control reduces microvascular complications in both type 1 and type 2 diabetes. Macrovascular complications predominate in type 2 diabetes, and the effect of tight control here is less clear. Treatment of other aspects of insulin resistance (BP, lipids) significantly reduces cardiovascular morbidity and mortality in type 2 diabetes. Insulin therapy has favorable effects on endothelial function and lipids, especially compared with sulfonylureas. More information is needed on the effects of diabetes pharmacotherapy on cardiovascular outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 501-505 |
| Number of pages | 5 |
| Journal | Journal of Association of Physicians of India |
| Volume | 51 |
| Issue number | MAY |
| State | Published - May 2003 |
ASJC Scopus subject areas
- General Medicine